We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
-1.45%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.91B
AUM Growth
-$58.7M
Cap. Flow
-$6.54M
Cap. Flow %
-0.34%
Top 10 Hldgs %
39.91%
Holding
252
New
15
Increased
80
Reduced
73
Closed
17

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$5.48M
2
MS icon
Morgan Stanley
MS
+$5.37M
3
PFE icon
Pfizer
PFE
+$4.76M
4
FAST icon
Fastenal
FAST
+$4.66M
5
TGT icon
Target
TGT
+$4.36M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$14.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$11.8M
3
DIS icon
Walt Disney
DIS
+$8.48M
4
LMT icon
Lockheed Martin
LMT
+$6.84M
5
TRV icon
Travelers Companies
TRV
+$3.24M

Sector Composition

Rank Sector Weight
1 Consumer Staples 24.07%
2 Technology 21.25%
3 Healthcare 12.53%
4 Financials 11.18%
5 Consumer Discretionary 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETN icon
101
Eaton
ETN
$173B
$3.85M 0.2%
25,391
-171
-0.7% -$26.8K
TRV icon
102
Travelers Companies
TRV
$78.7B
$3.71M 0.19%
20,300
-18,900
-48% -$3.24M
NOC icon
103
Northrop Grumman
NOC
$78.4B
$3.7M 0.19%
8,269
-5,200
-39% -$2.15M
HD icon
104
Home Depot
HD
$347B
$3.69M 0.19%
12,317
+320
+3% +$111K
SWK icon
105
Stanley Black & Decker
SWK
$15.5B
$3.56M 0.19%
25,432
+812
+3% +$134K
LULU icon
106
lululemon athletica
LULU
$14B
$3.37M 0.18%
9,226
-1,297
-12% -$422K
NVDA icon
107
NVIDIA
NVDA
$5.13T
$3.36M 0.18%
123,000
-19,000
-13% -$477K
PEP icon
108
PepsiCo
PEP
$190B
$3.27M 0.17%
19,546
-75
-0.4% -$12.6K
FDS icon
109
Factset
FDS
$9.76B
$2.93M 0.15%
6,740
-205
-3% -$86.5K
PM icon
110
Philip Morris
PM
$291B
$2.85M 0.15%
30,280
+600
+2% +$60K
IBM icon
111
IBM
IBM
$222B
$2.8M 0.15%
21,543
-4,562
-17% -$595K
FTV icon
112
Fortive
FTV
$18.3B
$2.73M 0.14%
59,383
-16,853
-22% -$833K
ROST icon
113
Ross Stores
ROST
$80.5B
$2.72M 0.14%
30,087
-8,100
-21% -$772K
CARR icon
114
Carrier Global
CARR
$54.1B
$2.7M 0.14%
58,800
+9,500
+19% +$447K
GOOG icon
115
Alphabet (Google) Class C
GOOG
$4.59T
$2.65M 0.14%
19,000
+4,000
+27% +$544K
AZN icon
116
AstraZeneca
AZN
$241B
$2.42M 0.13%
18,271
-509
-3% -$61K
DORM icon
117
Dorman Products
DORM
$4.42B
$2.38M 0.12%
25,000
– –
OKTA icon
118
Okta
OKTA
$25.7B
$2.17M 0.11%
14,400
– –
SO icon
119
Southern Company
SO
$107B
$1.87M 0.1%
25,820
+300
+1% +$20.3K
IVV icon
120
iShares Core S&P 500 ETF
IVV
$900B
$1.84M 0.1%
4,050
– –
GS icon
121
Goldman Sachs
GS
$311B
$1.74M 0.09%
5,270
-6,200
-54% -$2.19M
C icon
122
Citigroup
C
$230B
$1.71M 0.09%
32,026
-800
-2% -$49.4K
VLO icon
123
Valero Energy
VLO
$88.9B
$1.71M 0.09%
16,800
– –
MDLZ icon
124
Mondelez International
MDLZ
$79.2B
$1.68M 0.09%
26,760
– –
NSC icon
125
Norfolk Southern
NSC
$76.7B
$1.65M 0.09%
5,800
– –
3 4
5
6 7

Similar funds

MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
WGAM
Wilkinson Global Asset Management New York $1.31B AUM 17.03% 1-Year Est. Return

Cullinan Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Cullinan Associates held 252 positions worth $1.91B, down 3% from $1.96B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cullinan Associates's Q1 2022 filing shows 15 new, 80 increased, 73 reduced and 17 closed positions. Its largest new stake was West Pharmaceutical: 14,000 shares worth $5.75M. The largest sale was Walmart Inc, an estimated $14.5M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q1 2022 buy was West Pharmaceutical: 14,000 shares worth $5.75M.
  • Cullinan Associates added most to Morgan Stanley in Q1 2022, an estimated $5.37M increase.
  • Cullinan Associates's biggest Q1 2022 reduction was Walmart Inc, cutting an estimated $14.5M.
  • Cullinan Associates fully exited Vontier in Q1 2022, selling an estimated $758K.
  • Cullinan Associates's ten largest holdings make up 40% of its $1.91B portfolio in Q1 2022.
  • Cullinan Associates opened 15 new positions and closed 17 in Q1 2022.
  • Cullinan Associates's portfolio value fell 3% quarter-over-quarter to $1.91B.

Based on Cullinan Associates's 13F filing for Q1 2022, filed 21 Apr 2022.